Last Price$143.40.9%
Market Cap$47.9B
LTM EBITDA
$3,766.0M
YoY Growth
+22.8%
3Y CAGR
+5.1%
5Y CAGR
-0.3%
Stock quality & Intrinsic value
6/10
11.6% undervalued
Kimberly-Clark Corporation EBITDA
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | $3,155.1M | $3,034.3M | $3,422.9M | $3,322.0M | $3,637.0M | $3,609.0M | $3,554.0M | $3,559.0M | $4,091.0M | $3,401.0M | $2,376.0M | $4,033.0M | $4,033.0M | $2,958.0M | $3,828.0M | $3,978.0M | $3,247.0M | $3,376.0M | $3,067.0M | $3,978.0M |
Overvalued or undervalued?
Check the intrinsic value for KMB
and see if it's the right time to invest.
Kimberly-Clark Corporation (KMB) EBITDA comparison analysis
General
LTM EBITDA
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Kimberly-Clark CorporationKMB
$3,766.0M
22.8%
5.1%
(0.3%)
Median Peer Set
$971.9M
(1.8%)
3.7%
0.0%
Unilever PLCUL
$26.0B
15.2%
5.2%
6.9%
The Procter & Gamble CompanyPG
$23.3B
3.1%
3.6%
17.3%
Colgate-Palmolive CompanyCL
$4,961.0M
3.0%
3.9%
4.2%
Kenvue Inc.KVUE
$3,166.0M
(6.1%)
63.7%
N/A
Church & Dwight Co., Inc.CHD
$976.7M
(23.1%)
(9.1%)
(0.7%)
The Clorox CompanyCLX
$967.0M
92.6%
15.3%
(5.5%)
Coty Inc.COTY
$748.7M
(29.8%)
(5.1%)
N/A
The Estée Lauder Companies Inc.EL
$362.0M
(81.4%)
(57.6%)
(36.5%)
e.l.f. Beauty, Inc.ELF
$168.8M
(3.6%)
49.9%
25.5%
Hims & Hers Health, Inc.HIMS
$72.9M
N/A
N/A
N/A
KMB key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 15,902.6 5.4% | 16,746.9 5.3% | 18,266.0 9.1% | 19,415.0 6.3% | 19,115.0 (1.5%) | 19,746.0 3.3% | 20,846.0 5.6% | 21,063.0 1.0% | 21,152.0 0.4% | 19,724.0 (6.8%) | 18,591.0 (5.7%) | 18,202.0 (2.1%) | 18,259.0 0.3% | 18,486.0 1.2% | 18,450.0 (0.2%) | 19,140.0 3.7% | 19,440.0 1.6% | 20,175.0 3.8% | 20,431.0 1.3% | 20,058.0 (1.8%) |
| Cost of Goods Sold (COGS) | 10,827.4 | 11,664.8 | 12,562.1 | 13,557.0 | 12,695.0 | 13,196.0 | 14,694.0 | 14,314.0 | 13,912.0 | 13,041.0 | 11,967.0 | 11,551.0 | 11,706.0 | 12,889.0 | 12,415.0 | 12,318.0 | 13,452.0 | 13,956.0 | 13,399.0 | 12,878.0 |
% margin | 5,075.2 31.9% | 5,082.1 30.3% | 5,703.9 31.2% | 5,858.0 30.2% | 6,420.0 33.6% | 6,550.0 33.2% | 6,152.0 29.5% | 6,749.0 32.0% | 7,240.0 34.2% | 6,683.0 33.9% | 6,624.0 35.6% | 6,651.0 36.5% | 6,553.0 35.9% | 5,597.0 30.3% | 6,035.0 32.7% | 6,822.0 35.6% | 5,988.0 30.8% | 6,219.0 30.8% | 7,032.0 34.4% | 7,180.0 35.8% |
| Operating Expenses | 2,764.6 | 2,980.6 | 3,087.5 | 3,311.0 | 3,595.0 | 3,777.0 | 3,710.0 | 4,063.0 | 4,032.0 | 4,162.0 | 5,011.0 | 3,334.0 | 3,254.0 | 3,368.0 | 3,044.0 | 3,578.0 | 3,427.0 | 3,538.0 | 4,588.0 | 3,970.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 335.0 | 333.0 | 368.0 | 324.0 | 328.0 | 309.0 | 317.0 | 284.0 | 276.0 | 269.0 | 292.0 | 312.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 2,737.4 | 2,948.3 | 3,105.9 | 3,291.0 | 3,498.0 | 3,673.0 | 3,761.0 | 4,069.0 | 4,028.0 | 3,709.0 | 3,443.0 | 3,326.0 | 3,227.0 | 3,367.0 | 3,254.0 | 3,632.0 | 3,399.0 | 3,581.0 | 3,961.0 | 4,311.0 |
% margin | 2,310.6 14.5% | 2,101.5 12.5% | 2,616.4 14.3% | 2,547.0 13.1% | 2,825.0 14.8% | 2,773.0 14.0% | 2,442.0 11.7% | 2,686.0 12.8% | 3,208.0 15.2% | 2,521.0 12.8% | 1,613.0 8.7% | 3,317.0 18.2% | 3,299.0 18.1% | 2,229.0 12.1% | 2,991.0 16.2% | 3,244.0 16.9% | 2,561.0 13.2% | 2,681.0 13.3% | 2,344.0 11.5% | 3,210.0 16.0% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 26.0 | 20.0 | 18.0 | 18.0 | 20.0 | 18.0 | 17.0 | 11.0 | 10.0 | 10.0 | 11.0 | 8.0 | 6.0 | 14.0 | 66.0 | 48.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 275.0 | 243.0 | 277.0 | 284.0 | 283.0 | 284.0 | 295.0 | 319.0 | 318.0 | 263.0 | 261.0 | 252.0 | 256.0 | 282.0 | 293.0 | 270.0 |
| Pre-tax Income | 1,968.9 | 1,844.9 | 2,317.5 | 2,289.0 | 2,576.0 | 2,550.0 | 2,183.0 | 2,420.0 | 2,945.0 | 2,255.0 | 1,335.0 | 3,009.0 | 2,991.0 | 1,813.0 | 2,650.0 | 2,930.0 | 2,225.0 | 2,340.0 | 2,021.0 | 3,143.0 |
% effective tax rate | 438.4 22.3% | 469.2 25.4% | 536.5 23.1% | 618.0 27.0% | 746.0 29.0% | 788.0 30.9% | 660.0 30.2% | 768.0 31.7% | 929.0 31.5% | 856.0 38.0% | 418.0 31.3% | 922.0 30.6% | 776.0 25.9% | 471.0 26.0% | 576.0 21.7% | 676.0 23.1% | 479.0 21.5% | 495.0 21.2% | 453.0 22.4% | 565.0 18.0% |
% margin | 1,568.3 9.9% | 1,499.5 9.0% | 1,822.9 10.0% | 1,690.0 8.7% | 1,884.0 9.9% | 1,843.0 9.3% | 1,591.0 7.6% | 1,750.0 8.3% | 2,142.0 10.1% | 1,526.0 7.7% | 1,013.0 5.4% | 2,166.0 11.9% | 2,278.0 12.5% | 1,410.0 7.6% | 2,157.0 11.7% | 2,352.0 12.3% | 1,814.0 9.3% | 1,934.0 9.6% | 1,764.0 8.6% | 2,545.0 12.7% |
| EPS | 3.30 | 3.27 | 4.13 | 4.06 | 4.53 | 4.47 | 4.02 | 4.45 | 5.58 | 4.07 | 2.78 | 6.03 | 6.44 | 4.05 | 6.28 | 6.90 | 5.38 | 5.73 | 5.21 | 7.58 |
| Diluted EPS | 3.28 | 3.25 | 4.09 | 4.04 | 4.52 | 4.45 | 3.99 | 4.42 | 5.53 | 4.04 | 2.77 | 5.99 | 6.40 | 4.03 | 6.24 | 6.87 | 5.35 | 5.72 | 5.21 | 7.55 |
% margin | 3,155.1 19.8% | 3,034.3 18.1% | 3,422.9 18.7% | 3,322.0 17.1% | 3,637.0 19.0% | 3,609.0 18.3% | 3,554.0 17.0% | 3,559.0 16.9% | 4,091.0 19.3% | 3,401.0 17.2% | 2,376.0 12.8% | 4,033.0 22.2% | 4,033.0 22.1% | 2,958.0 16.0% | 3,828.0 20.7% | 3,978.0 20.8% | 3,247.0 16.7% | 3,376.0 16.7% | 3,067.0 15.0% | 3,978.0 19.8% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Kimberly-Clark Corporation's EBITDA?
As of today, Kimberly-Clark Corporation's last 12-month EBITDA is $3,766.0M, based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Kimberly-Clark Corporation's EBITDA growth rate?
Over the last year, Kimberly-Clark Corporation's EBITDA growth was 22.8%. The average annual EBITDA growth rates for Kimberly-Clark Corporation have been 3.0% over the past three years, (0.3%) over the past five years.
3) Is Kimberly-Clark Corporation's EBITDA growth rate Good?
Over the last year, Kimberly-Clark Corporation's EBITDA growth was 22.8%, which is higher than industry growth of 0.2%. It indicates that Kimberly-Clark Corporation's EBITDA growth is Good.